Загрузка...
Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent
OBJECTIVES: To analyse the effect of biological agents (BAs) in terms of achieving inactive disease (ID) or clinical remission (CR) in patients with systemic juvenile idiopathic arthritis (SJIA), to describe effects of switching or discontinuing a BA and to assess the proportion of patients able to...
Сохранить в:
| Опубликовано в: : | RMD Open |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4613174/ https://ncbi.nlm.nih.gov/pubmed/26509061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2014-000036 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|